Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia

Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia

Acute Myeloid Leukaemia (AML) is a rare but serious group of diseases that require critical decision-making for curative treatment. Over the past decade, scientific discovery has revealed dozens of prognostic gene mutations for AML while sequencing costs have plummeted. In this study, we compared th...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Cressman, S, Karsan, A, Hogge, DE, McPherson, E, Bolbocean, C, Regier, DA, Peacock, SJ
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Wiley 2016

Gelijkaardige items

Quality of life and socioeconomic indicators associated with survival of myeloid leukemias in Canada
door: Sonya Cressman, et al.
Gepubliceerd in: (2020-07-01)

Hypocellular Acute Myeloid Leukaemia-A Diagnostic Conundrum
door: Sindhura Lakshmi Koulmane Laxminarayana, et al.
Gepubliceerd in: (2018-12-01)

Acute Myeloid Leukaemia with Plasmacytosis
door: Yasmin Akhtar, Saqib Qayyum Ahmad, Shahid Jamal
Gepubliceerd in: (2016-12-01)

Exploring the acute myeloid leukaemias
door: TB Thapa
Gepubliceerd in: (2013-10-01)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
door: Eden, O, et al.
Gepubliceerd in: (1998)

Acute myeloid leukaemia with aberrant expression of pancytokeratin: A diagnostic pitfall
door: Yasin Dhonye, et al.
Gepubliceerd in: (2023-02-01)

DISTINCTION BETWEEN ACUTE MYELOID LEUKAEMIA WITH MYELODYSPLASIA-RELATED CHANGES AND MIXED-PHENOTYPE ACUTE LEUKAEMIA: A DIAGNOSTIC CHALLENGE
door: NA Marcondes, et al.
Gepubliceerd in: (2021-10-01)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
door: Sweeney, C
Gepubliceerd in: (2021)

Adhesion Deregulation in Acute Myeloid Leukaemia
door: Alicja M. Gruszka, et al.
Gepubliceerd in: (2019-01-01)

Wnt Signalling in Acute Myeloid Leukaemia
door: Alicja M. Gruszka, et al.
Gepubliceerd in: (2019-11-01)

Orbital deposit in acute myeloid leukaemia
door: Seal G, et al.
Gepubliceerd in: (1973-01-01)

Prediction of acute myeloid leukaemia risk in healthy individuals
door: Abelson, S, et al.
Gepubliceerd in: (2018)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
door: Guinn, B, et al.
Gepubliceerd in: (2005)

Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia
door: Sitânia Chiesa, et al.
Gepubliceerd in: (2024-12-01)

Amplification of mitochondrial DNA in acute myeloid leukaemia.
door: Boultwood, J, et al.
Gepubliceerd in: (1996)

Immunological weapons against acute myeloid leukaemia.
door: Galea-Lauri, J
Gepubliceerd in: (2002)

C/EBPalpha mutations in acute myeloid leukaemias.
door: Nerlov, C
Gepubliceerd in: (2004)

EVI1 expression in acute myeloid leukaemia.
door: Langabeer, SE, et al.
Gepubliceerd in: (2001)

New Therapeutic Approaches for Acute Myeloid Leukaemia
door: Ruth M Risueno, et al.
Gepubliceerd in: (2021-06-01)

Acute Myeloid Leukaemia Presenting as Gaze Palsy
door: Evripidis Sykakis, et al.
Gepubliceerd in: (2011-11-01)

Pharmacogenomics and regulation of apoptosis in acute myeloid leukaemia
door: Pravdić Zlatko, et al.
Gepubliceerd in: (2020-01-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
door: R Edlin, et al.
Gepubliceerd in: (2010-05-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
door: R Edlin, et al.
Gepubliceerd in: (2010-05-01)

Expression of Aberrant Markers and its Association with Remission Postinduction Therapy in Acute Lymphoblastic Leukaemia and Acute Myeloid Leukaemia
door: Subbaramaiah Shwetha, et al.
Gepubliceerd in: (2021-07-01)

P580: THE USE OF LEUKAEMIA Q-FUSION GENE SCREENING ASSAY (Q30) IN THE DIAGNOSTIC EVALUATION OF ACUTE MYELOID LEUKAEMIA (AML)
door: S. Tayabali, et al.
Gepubliceerd in: (2022-06-01)

From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia
door: Jakobsen, N, et al.
Gepubliceerd in: (2018)

OUTCOME OF CHEMOTHERAPY IN NON ACUTE PROMYELOCYTIC ACUTE MYELOID LEUKAEMIA
door: Nighat Shahbaz, et al.
Gepubliceerd in: (2020-10-01)

OUTCOME OF CHEMOTHERAPY IN NON ACUTE PROMYELOCYTIC ACUTE MYELOID LEUKAEMIA
door: Nighat Shahbaz, et al.
Gepubliceerd in: (2020-10-01)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
door: Boultwood, J, et al.
Gepubliceerd in: (2004)

Less utilized prognostic markers in acute myeloid leukaemia
door: Abdullah, Maha
Gepubliceerd in: (2016)

Improved outcome of acute myeloid leukaemia in Down's syndrome.
door: Craze, J, et al.
Gepubliceerd in: (1999)

Randomised studies in acute myeloid leukaemia: the double truth
door: Richards, S
Gepubliceerd in: (2000)

Detection of Cup-like Blasts in Acute Myeloid Leukaemia
door: Supriya Mehrotra, et al.
Gepubliceerd in: (2019-10-01)

Phlegmonous gastritis as the initial presentation of acute myeloid leukaemia
door: Shin Lee, et al.
Gepubliceerd in: (2022-08-01)

Chronic myeloid leukaemia presenting as acute pulmonary thromboembolism
door: Shetty Mallikarjuna, et al.
Gepubliceerd in: (2022-01-01)

Granulocytic Sarcoma in an Adult with Relapsed Acute Myeloid Leukaemia
door: Neethu Ann Kurien, et al.
Gepubliceerd in: (2016-01-01)

Unilateral proptosis: extramedullary manifestation of acute myeloid leukaemia
door: Pallavi Gahlowt, et al.
Gepubliceerd in: (2016-03-01)

Clinico-haematological and Cytochemical Study of Acute Myeloid Leukaemia
door: Anil Meena, et al.
Gepubliceerd in: (2020-10-01)

Transcriptional Regulation by the NFAT Family in Acute Myeloid Leukaemia
door: Shaun D. Patterson, et al.
Gepubliceerd in: (2021-08-01)

ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia
door: Mohd Amin, A, et al.
Gepubliceerd in: (2023)